Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Lymphoma and C2[original query] |
|---|
| Role of genetic factors in development and progression of non-Hodgkin's lymphomas. Central European journal of public health 2001 May 9 (2): 74-8. Soucek |
| Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. British journal of haematology 2009 Jun 145 (5): 614-23. Cerhan James R, Novak Anne J, Fredericksen Zachary S, Wang Alice H, Liebow Mark, Call Timothy G, Dogan Ahmet, Witzig Thomas E, Ansell Stephen M, Habermann Thomas M, Kay Neil E, Slager Susan |
| Polymorphisms in complement system genes and risk of non-Hodgkin lymphoma. Environmental and molecular mutagenesis 2012 Mar 53 (2): 2. Bassig BA, Zheng T, Zhang Y, Berndt SI, Holford TR, Hosgood HD, Hu W, Leaderer B, Yeager M, Menashe I, Boyle P, Xu J, Zou K, Zhu Y, Chanock S, Rothman N, Lan Q |
| The impact of HLA-C matching depends on the C1/C2 KIR ligand status in unrelated hematopoietic stem cell transplantation. Immunogenetics 2012 Dec 64 (12): 879-85. Fischer Johannes C, Kobbe Guido, Enczmann Jürgen, Haas Rainer, Uhrberg Mark |
| Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 12 24 (4): 717-725. Arima Nobuyoshi, Kanda Junya, Tanaka Junji, Yabe Toshio, Morishima Yasuo, Kim Sung-Won, Najima Yuho, Ozawa Yukiyasu, Eto Tetsuya, Kanamori Heiwa, Mori Takehiko, Kobayashi Naoki, Kondo Tadakazu, Nakamae Hirohisa, Uchida Naoyuki, Inoue Masami, Fukuda Takahiro, Ichinohe Tatsuo, Atsuta Yoshiko, Kanda Yoshino |
| Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response. Oncoimmunology 2021 6 10 (1): 1936392. Makanga Dhon Roméo, Jullien Maxime, David Gaëlle, Legrand Nolwenn, Willem Catherine, Dubreuil Léa, Walencik Alexandre, Touzeau Cyrille, Gastinne Thomas, Tessoulin Benoit, Le Gouill Steven, Mahé Béatrice, Gagne Katia, Chevallier Patrice, Clemenceau Béatrice, Retière Christel |
| Study on Relationships of Tumor Status and Gene Polymorphism With Blood Concentration of MTX and Toxicities in 63 Pediatric Mature B Cell Lymphoma in Chinese Population. Technology in cancer research & treatment 0 20 1533033821995288. Huang Shuang, Jin Lin, Yang Jing, Duan Long Yan, Zhang Meng, Zhou Ju Chun, Zhang Hong Yo |
| KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials. The Lancet. Haematology 2022 2 9 (2): e133-e142. Kaddu-Mulindwa Dominic, Altmann Bettina, Robrecht Sandra, Ziepert Marita, Regitz Evi, Tausch Eugen, Held Gerhard, Poeschel Viola, Lesan Vadim, Bittenbring Joerg Thomas, Thurner Lorenz, Pfreundschuh Michael, Christofyllakis Konstantinos, Truemper Lorenz, Loeffler Markus, Schmitz Norbert, Hoth Markus, Hallek Michael, Fischer Kirsten, Stilgenbauer Stephan, Bewarder Moritz, Rixecker Torben Milla |
| Genomic landscape and distinct molecular subtypes of primary testicular lymphoma. Journal of translational medicine 2024 5 22 (1): 414. Weilong Zhang, Ping Yang, Yaru Yang, Shuozi Liu, Yongdeng Xu, Chaoling Wu, Jing Wang, Cuiling Liu, Hui Liu, Shuangshuang Li, Wei Huang, Hongmei Ji |
- Page last reviewed:Feb 1, 2024
- Content source: